Exchange: OTC·Updated 03:59 PM EST

EVFM News

News
all
press releases
Aditxt and Evofem file for stockholder approval to finalize their merger in Q4 2024. The acquisition will position Evofem as a wholly owned Aditxt subsidiary, enhancing their women’s health portfolio.
Sponsored

Advertisement|Remove ads.